LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.75 | 770.25 | 11307 | 11262 | 1.0039 | 1.0020 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.75 | 770.25 | 11694 | 11262 | 1.0383 | 1.0195 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.98 | 770.25 | 11538 | 11518 | 1.0017 | 1.0009 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.98 | 770.25 | 12053 | 11518 | 1.0464 | 1.0234 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.20 | 770.25 | 11948 | 11766 | 1.0154 | 1.0078 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.20 | 770.25 | 12479 | 11766 | 1.0606 | 1.0301 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.42 | 770.25 | 12215 | 12031 | 1.0152 | 1.0076 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.42 | 770.25 | 12644 | 12031 | 1.0509 | 1.0252 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.64 | 770.25 | 12573 | 12287 | 1.0232 | 1.0115 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.64 | 770.25 | 13080 | 12287 | 1.0645 | 1.0315 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 770.25 | 12967 | 12543 | 1.0338 | 1.0166 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 770.25 | 13404 | 12543 | 1.0686 | 1.0332 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 3.21 | 770.25 | 849 | 904 | 0.9385 | 0.5214 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 3.21 | 770.25 | 992 | 904 | 1.0966 | 1.9760 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.44 | 770.25 | 918 | 1012 | 0.9064 | 0.5596 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.44 | 770.25 | 1093 | 1012 | 1.0792 | 1.4260 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.66 | 770.25 | 1013 | 1090 | 0.9294 | 0.7279 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.66 | 770.25 | 1183 | 1090 | 1.0853 | 1.3551 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.06 | 770.25 | 1105 | 1218 | 0.9069 | 0.7253 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.06 | 770.25 | 1299 | 1218 | 1.0661 | 1.2030 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.28 | 770.25 | 1259 | 1358 | 0.9270 | 0.8231 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.28 | 770.25 | 1467 | 1358 | 1.0802 | 1.1977 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.50 | 770.25 | 1378 | 1497 | 0.9204 | 0.8342 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.50 | 770.25 | 1672 | 1497 | 1.1167 | 1.2440 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.73 | 770.25 | 1538 | 1664 | 0.9240 | 0.8627 | MN20160304_L02 | F15 |